Metrohealth is a clinical research site located in Cleveland, Ohio, United States.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
Metrohealth has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Coronary Artery Disease, Atherosclerosis, Neonatal Opioid Withdrawal Syndrome.
Sponsors: Infraredx, Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program, Novartis Pharmaceuticals.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Metrohealth has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Metrohealth has 4 clinical trials on record, with 1 currently active. Their work covers Coronary Artery Disease, Atherosclerosis, Neonatal Opioid Withdrawal Syndrome.
Metrohealth has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.